NO20041003L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number: NO20041003L
Authority: NO; Norway
Prior art keywords: new connections; connections; new
Prior art date: 2001-09-13

Application number

NO20041003A

Other languages

English (en)

Other versions

NO327009B1 (no

Inventor

Paul Adrian Wyman

Mervyn Thompson

Harshad Kantilal Rami

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-13

Filing date

2004-03-10

Publication date

2004-06-04

2001-09-13 Priority claimed from GB0122156A external-priority patent/GB0122156D0/en

2001-12-20 Priority claimed from GB0130547A external-priority patent/GB0130547D0/en

2001-12-20 Priority claimed from GB0130505A external-priority patent/GB0130505D0/en

2001-12-20 Priority claimed from GB0130503A external-priority patent/GB0130503D0/en

2004-03-10 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-06-04 Publication of NO20041003L publication Critical patent/NO20041003L/no

2009-04-06 Publication of NO327009B1 publication Critical patent/NO327009B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

NO20041003A 2001-09-13 2004-03-10 Nye forbindelser, fremgangsmate for fremstilling derav, anvendelse av forbindelsen samt farmasoytisk preparat omfattende denne NO327009B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0122156A GB0122156D0 (en)	2001-09-13	2001-09-13	Novel compounds
GB0130547A GB0130547D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130505A GB0130505D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130503A GB0130503D0 (en)	2001-12-20	2001-12-20	Novel compounds
PCT/GB2002/004206 WO2003022809A2 (en)	2001-09-13	2002-09-13	Urea-compounds active as vanilloid receptor antagonists for the treatment of pain

Publications (2)

Publication Number	Publication Date
NO20041003L true NO20041003L (no)	2004-06-04
NO327009B1 NO327009B1 (no)	2009-04-06

Family

ID=27447989

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20041003A NO327009B1 (no)	2001-09-13	2004-03-10	Nye forbindelser, fremgangsmate for fremstilling derav, anvendelse av forbindelsen samt farmasoytisk preparat omfattende denne
NO20085078A NO20085078L (no)	2001-09-13	2008-12-04	Nye forbindelser
NO20085077A NO20085077L (no)	2001-09-13	2008-12-04	Nye forbindelser

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO20085078A NO20085078L (no)	2001-09-13	2008-12-04	Nye forbindelser
NO20085077A NO20085077L (no)	2001-09-13	2008-12-04	Nye forbindelser

Country Status (32)

Country	Link
US (1)	US8063078B2 (no)
EP (3)	EP1425277B8 (no)
JP (2)	JP4463552B2 (no)
KR (3)	KR100955967B1 (no)
CN (1)	CN1247568C (no)
AP (1)	AP1818A (no)
AR (1)	AR038786A1 (no)
AT (1)	ATE420083T1 (no)
AU (1)	AU2002329397B2 (no)
BR (1)	BR0212468A (no)
CA (1)	CA2458632C (no)
CY (1)	CY1109449T1 (no)
DE (1)	DE60230773D1 (no)
DK (1)	DK1425277T3 (no)
EA (1)	EA007731B1 (no)
ES (1)	ES2316607T3 (no)
HK (1)	HK1066534A1 (no)
HU (1)	HUP0401923A3 (no)
IL (2)	IL160755A0 (no)
MA (1)	MA26216A1 (no)
MX (1)	MXPA04002379A (no)
MY (1)	MY138086A (no)
NO (3)	NO327009B1 (no)
NZ (1)	NZ531137A (no)
OA (1)	OA12659A (no)
PE (1)	PE20030417A1 (no)
PL (1)	PL213639B1 (no)
PT (1)	PT1425277E (no)
SI (1)	SI1425277T1 (no)
TW (1)	TWI283665B (no)
UY (1)	UY27446A1 (no)
WO (1)	WO2003022809A2 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY138086A (en)	2001-09-13	2009-04-30	Smithkline Beecham Plc	Novel urea derivative as vanilloid receptor-1 antagonist
DE60332316D1 (de)	2002-02-01	2010-06-10	Euro Celtique Sa	2-piperazinpyridine für die schmerzbehandlung
US7074805B2 (en)	2002-02-20	2006-07-11	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
EP1478363B1 (en) *	2002-02-20	2009-01-14	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
US6974818B2 (en)	2002-03-01	2005-12-13	Euro-Celtique S.A.	1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
DE60318875T2 (de)	2002-06-28	2009-01-15	Euro-Celtique S.A.	Therapeutische piperazin-derivate für die behandlung von schmerzen
US7262194B2 (en)	2002-07-26	2007-08-28	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
GB0221157D0 (en) *	2002-09-12	2002-10-23	Glaxo Group Ltd	Novel treatment
WO2004024710A1 (en) *	2002-09-13	2004-03-25	Glaxo Group Limited	Urea compounds active as vanilloid receptor antagonists for the treatment of pain
US7157462B2 (en)	2002-09-24	2007-01-02	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
US7381840B2 (en)	2002-12-06	2008-06-03	Xention Limited	Tetrahydro-naphthalene derivatives
GB0229808D0 (en)	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
US6933311B2 (en) *	2003-02-11	2005-08-23	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ES2330107T3 (es)	2003-03-06	2009-12-04	Glaxo Group Limited	Derivados de urea heterociclicos para el tratamiento del dolor.
US7514562B2 (en)	2003-03-07	2009-04-07	Glaxo Group Limited	Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0305426D0 (en) *	2003-03-08	2003-04-16	Glaxo Group Ltd	Novel compounds
SE0301446D0 (sv)	2003-05-16	2003-05-16	Astrazeneca Ab	New Compounds
ATE556067T1 (de)	2003-05-20	2012-05-15	Ajinomoto Kk	Modulatoren des vanilloid rezeptors
EP1493438A1 (en) *	2003-07-03	2005-01-05	Bayer HealthCare AG	Vanilloid receptor (VR) inhibitors for treatment of Human Immunodeficiency Virus (HIV)-mediated pain states
GB0319150D0 (en)	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
GB0319151D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
DE602004019294D1 (de)	2003-10-01	2009-03-19	Xention Ltd	Tetrahydronaphthalin- und harnstoffderivate
EP1679296A4 (en)	2003-10-14	2007-12-26	Ajinomoto Kk	DERIVE ETHERE
US20080045546A1 (en) *	2003-10-15	2008-02-21	Axel Bouchon	Tetradydro-Naphthalene And Urea Derivatives
CA2545109A1 (en)	2003-11-08	2005-05-19	Bayer Healthcare Ag	Tetrahydro-quinolinylurea derivatives
WO2005095327A1 (ja) *	2004-03-31	2005-10-13	Ajinomoto Co., Inc.	アニリン誘導体
US7687665B2 (en)	2004-06-24	2010-03-30	Incyte Corporation	2-methylprop anamides and their use as pharmaceuticals
WO2006007851A2 (en)	2004-07-19	2006-01-26	Novo Nordisk A/S	Capsaicin inhibitors for treating obesity and-related disorders
KR20060087386A (ko)	2005-01-28	2006-08-02	주식회사 대웅제약	신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
WO2006098554A1 (en) *	2005-03-16	2006-09-21	Amorepacific Corporation	Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same
WO2007046867A2 (en) *	2005-05-19	2007-04-26	Xenon Pharmaceuticals Inc.	Piperidine derivatives and their uses as therapeutic agents
AR058705A1 (es)	2005-12-23	2008-02-20	Astrazeneca Ab	Compuestos de bencimidazol como inhibidores del receptor vaniloide 1 (vr1)
EP1889830A1 (en) *	2006-07-10	2008-02-20	Pharmeste S.r.l.	Biarylcarboxyarylamides as vanilloid-1 receptor modulators
EP1882687A1 (en) *	2006-07-27	2008-01-30	Amorepacific Corporation	Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same
EP2054411B1 (en) *	2006-07-27	2014-08-20	Amorepacific Corporation	Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
TWI433839B (zh)	2006-08-11	2014-04-11	Neomed Inst	新穎的苯并咪唑衍生物290
MX2009002018A (es)	2006-08-25	2009-03-05	Abbott Lab	Derivados de indazol que inhiben vanilloide-1 potencial de receptor pasajero (trpv1) y usos de los mismos.
WO2008079683A2 (en)	2006-12-20	2008-07-03	Abbott Laboratories	N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
US8232411B2 (en)	2008-03-20	2012-07-31	Abbott Laboratories	Methods for making central nervous system agents that are TRPV1 antagonists
WO2009128661A2 (ko)	2008-04-18	2009-10-22	주식회사 대웅제약	신규 벤조옥사진 벤즈이미다졸 유도체, 이를 포함하는 약학 조성물 및 이의 용도
EP2277861A4 (en) *	2008-05-07	2012-05-02	Dainippon Sumitomo Pharma Co	CYCLIC AMIN-1-CARBOXYLIC ACID EST DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH
WO2010026129A1 (en) *	2008-09-02	2010-03-11	Glaxo Group Limited	The trpvl antagonist sb-705498 for treating rhinitis
WO2010026128A1 (en) *	2008-09-02	2010-03-11	Glaxo Group Limited	N-(3-methyl-5-isoquinolinyl)-n'-((3r)-1-[5-(trifluoromethyl)-2-pyridinyl]-3-pyrrolidinyl) urea for the treatment of rhinitis
JP2013028536A (ja) *	2009-11-11	2013-02-07	Dainippon Sumitomo Pharma Co Ltd	環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物
WO2012045729A1 (en)	2010-10-05	2012-04-12	Glaxo Group Limited	Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
KR101293384B1 (ko)	2010-10-13	2013-08-05	주식회사 대웅제약	신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도
WO2012072512A1 (en)	2010-11-29	2012-06-07	Glaxo Group Limited	N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
GB201101517D0 (en) *	2011-01-28	2011-03-16	Proximagen Ltd	Receptor antagonists
US8754101B2 (en)	2011-04-11	2014-06-17	Glaxo Group Limited	N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists
DE102022104759A1 (de)	2022-02-28	2023-08-31	SCi Kontor GmbH	Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3424760A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
US3424761A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
GB1460389A (en) *	1974-07-25	1977-01-06	Pfizer Ltd	4-substituted quinazoline cardiac stimulants
EP0347000B1 (en)	1988-06-17	1994-10-26	The Procter & Gamble Company	The use of vanilloids for the manufacture of a medicament for treating herpes simplex infections
HU206082B (en)	1988-12-23	1992-08-28	Sandoz Ag	Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
CA2017383A1 (en)	1989-06-08	1990-12-08	Raymond R. Martodam	Use of vanilloids for the treatment of respiratory diseases or disorders
AU9079491A (en)	1990-11-27	1992-06-25	Procter & Gamble Company, The	Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
US5149704A (en)	1991-05-03	1992-09-22	Abbott Laboratories	Platelet activating antagonists
CA2197364A1 (en) *	1996-02-15	1997-08-16	Toshikazu Suzuki	Phenol compound and process for preparing the same
IL133621A0 (en) *	1997-06-26	2001-04-30	Lilly Co Eli	Antithrombotic agents
ATE297203T1 (de) *	1997-06-26	2005-06-15	Lilly Co Eli	Antithrombotische mitteln
JP2000080085A (ja)	1997-09-01	2000-03-21	Kyorin Pharmaceut Co Ltd	６，７−非対称ジ置換キノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法
AU763824B2 (en)	1999-02-22	2003-07-31	Medifron Dbt Co., Ltd.	Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
YU64701A (sh)	1999-03-12	2004-05-12	Boehringen Ingelheim Pharmaceuticals Inc.	Jedinjenja upotrebljiva kao anti-inflamatorna sredstva
CA2384240A1 (en) *	1999-10-15	2001-04-26	Dean A. Wacker	Benzylcycloalkyl amines as modulators of chemokine receptor activity
IL153884A0 (en)	2000-07-20	2003-07-31	Neurogen Corp	Capsaicin receptor ligands
NZ523882A (en)	2000-08-21	2004-11-26	Pacific Corp	Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2002016317A1 (en)	2000-08-21	2002-02-28	Pacific Corporation	Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
US7067553B2 (en)	2000-08-21	2006-06-27	Pacific Corporation	Thiourea compounds and the pharmaceutical compositions containing the same
JP2002080073A (ja)	2000-09-07	2002-03-19	Kyokuto Kobunshi Kk	電子レンジ用自動開孔袋
JP2002088073A (ja) *	2000-09-08	2002-03-27	Yamanouchi Pharmaceut Co Ltd	抗アンドロゲン剤
GB0110901D0 (en)	2001-05-02	2001-06-27	Smithkline Beecham Plc	Novel Compounds
MY138086A (en) *	2001-09-13	2009-04-30	Smithkline Beecham Plc	Novel urea derivative as vanilloid receptor-1 antagonist
EP1534681A1 (en) *	2002-06-27	2005-06-01	Schering Aktiengesellschaft	Substituted quinoline ccr5 receptor antagonists
WO2004024710A1 (en)	2002-09-13	2004-03-25	Glaxo Group Limited	Urea compounds active as vanilloid receptor antagonists for the treatment of pain
GB0229808D0 (en)	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
CA2563494A1 (en)	2004-04-20	2005-11-03	Bayer Healthcare Ag	Urea derivatives as antagonists of the vanilloid receptor (vr1)

2002
- 2002-09-11 MY MYPI20023391A patent/MY138086A/en unknown
- 2002-09-11 TW TW091120671A patent/TWI283665B/zh not_active IP Right Cessation
- 2002-09-11 PE PE2002000895A patent/PE20030417A1/es not_active Application Discontinuation
- 2002-09-12 AR ARP020103454A patent/AR038786A1/es active IP Right Grant
- 2002-09-12 UY UY27446A patent/UY27446A1/es not_active Application Discontinuation
- 2002-09-13 AT AT02765023T patent/ATE420083T1/de active
- 2002-09-13 KR KR1020097003812A patent/KR100955967B1/ko not_active IP Right Cessation
- 2002-09-13 DK DK02765023T patent/DK1425277T3/da active
- 2002-09-13 JP JP2003526885A patent/JP4463552B2/ja not_active Expired - Fee Related
- 2002-09-13 PT PT02765023T patent/PT1425277E/pt unknown
- 2002-09-13 HU HU0401923A patent/HUP0401923A3/hu unknown
- 2002-09-13 ES ES02765023T patent/ES2316607T3/es not_active Expired - Lifetime
- 2002-09-13 CN CNB028177177A patent/CN1247568C/zh not_active Expired - Fee Related
- 2002-09-13 EA EA200400432A patent/EA007731B1/ru not_active IP Right Cessation
- 2002-09-13 BR BR0212468-8A patent/BR0212468A/pt not_active IP Right Cessation
- 2002-09-13 OA OA1200400070A patent/OA12659A/en unknown
- 2002-09-13 EP EP02765023A patent/EP1425277B8/en not_active Expired - Lifetime
- 2002-09-13 PL PL369026A patent/PL213639B1/pl not_active IP Right Cessation
- 2002-09-13 NZ NZ531137A patent/NZ531137A/en not_active IP Right Cessation
- 2002-09-13 KR KR1020047003680A patent/KR101063679B1/ko not_active IP Right Cessation
- 2002-09-13 US US10/489,277 patent/US8063078B2/en not_active Expired - Fee Related
- 2002-09-13 CA CA2458632A patent/CA2458632C/en not_active Expired - Fee Related
- 2002-09-13 KR KR1020107014626A patent/KR20100082390A/ko not_active Application Discontinuation
- 2002-09-13 EP EP10179466A patent/EP2298757A3/en not_active Withdrawn
- 2002-09-13 AP APAP/P/2004/002982A patent/AP1818A/en active
- 2002-09-13 MX MXPA04002379A patent/MXPA04002379A/es active IP Right Grant
- 2002-09-13 AU AU2002329397A patent/AU2002329397B2/en not_active Ceased
- 2002-09-13 WO PCT/GB2002/004206 patent/WO2003022809A2/en active Application Filing
- 2002-09-13 DE DE60230773T patent/DE60230773D1/de not_active Expired - Lifetime
- 2002-09-13 EP EP08172882A patent/EP2036902A3/en not_active Withdrawn
- 2002-09-13 IL IL16075502A patent/IL160755A0/xx unknown
- 2002-09-13 SI SI200230792T patent/SI1425277T1/sl unknown
2004
- 2004-03-04 IL IL160755A patent/IL160755A/en not_active IP Right Cessation
- 2004-03-10 NO NO20041003A patent/NO327009B1/no not_active IP Right Cessation
- 2004-03-12 MA MA27573A patent/MA26216A1/fr unknown
- 2004-11-30 HK HK04109442.1A patent/HK1066534A1/xx unknown
2008
- 2008-12-04 NO NO20085078A patent/NO20085078L/no unknown
- 2008-12-04 NO NO20085077A patent/NO20085077L/no not_active Application Discontinuation
2009
- 2009-03-19 CY CY20091100306T patent/CY1109449T1/el unknown
- 2009-12-08 JP JP2009278584A patent/JP2010100632A/ja active Pending

Also Published As

Publication number	Publication date
PL213639B1 (pl)	2013-04-30
DK1425277T3 (da)	2009-03-16
EP2036902A3 (en)	2009-05-06
JP4463552B2 (ja)	2010-05-19
EP2036902A2 (en)	2009-03-18
PE20030417A1 (es)	2003-08-06
CA2458632A1 (en)	2003-03-20
IL160755A0 (en)	2004-08-31
DE60230773D1 (de)	2009-02-26
JP2005504074A (ja)	2005-02-10
KR20040041610A (ko)	2004-05-17
KR20100082390A (ko)	2010-07-16
PT1425277E (pt)	2009-03-05
US20090163506A1 (en)	2009-06-25
EA200400432A1 (ru)	2004-12-30
EP2298757A2 (en)	2011-03-23
MY138086A (en)	2009-04-30
CN1553905A (zh)	2004-12-08
AP2004002982A0 (en)	2004-03-31
UY27446A1 (es)	2003-04-30
EP1425277B1 (en)	2009-01-07
NO20085077L (no)	2004-06-04
WO2003022809A3 (en)	2003-07-17
EP2298757A3 (en)	2011-12-28
EA007731B1 (ru)	2006-12-29
ES2316607T3 (es)	2009-04-16
HUP0401923A3 (en)	2012-09-28
KR20090026369A (ko)	2009-03-12
EP1425277B8 (en)	2009-04-01
KR101063679B1 (ko)	2011-09-07
WO2003022809A2 (en)	2003-03-20
SI1425277T1 (sl)	2009-04-30
AP1818A (en)	2008-01-07
ATE420083T1 (de)	2009-01-15
NO327009B1 (no)	2009-04-06
CY1109449T1 (el)	2014-08-13
HK1066534A1 (en)	2005-03-24
KR100955967B1 (ko)	2010-05-04
CA2458632C (en)	2011-08-23
AU2002329397B2 (en)	2006-04-27
MXPA04002379A (es)	2004-05-31
CN1247568C (zh)	2006-03-29
EP1425277A2 (en)	2004-06-09
PL369026A1 (en)	2005-04-18
HUP0401923A2 (hu)	2005-01-28
IL160755A (en)	2009-09-01
NO20085078L (no)	2004-06-04
JP2010100632A (ja)	2010-05-06
US8063078B2 (en)	2011-11-22
AR038786A1 (es)	2005-01-26
OA12659A (en)	2006-06-19
MA26216A1 (fr)	2004-07-01
BR0212468A (pt)	2004-10-19
TWI283665B (en)	2007-07-11
NZ531137A (en)	2006-08-31

Publication	Publication Date	Title
NO20040014L (no)	2004-03-02	Nye forbindelser
NO20041003L (no)	2004-06-04	Nye forbindelser
NO20034665D0 (no)	2003-10-17	Nye forbindelser
NO20035428D0 (no)	2003-12-05	Nye anti-ineffektiver
NO20034992D0 (no)	2003-11-10	Nye 4-aninlinokinolin-3-karboksamider
NO20026064L (no)	2003-02-17	Nye forbindelser
NO20023934L (no)	2002-10-07	Nye forbindelser
NO20044588L (no)	2004-10-25	Nye forbindelser
NO20044432L (no)	2004-10-19	Nye forbindelser
DE60227853D1 (de)	2008-09-04	Substituierte Pyridinylamine
NO20034308L (no)	2003-11-26	Nye tyrokinase-inhibitorer
NO20055219D0 (no)	2005-11-04	Nye forbindelser
NO20034970D0 (no)	2003-11-07	Nye arylheteroalkylaminderivater
DE60219284D1 (de)	2007-05-16	Dreischichtige maschenware
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
NO20034773D0 (no)	2003-10-24	Nye ftalazinoner
NO20025151D0 (no)	2002-10-25	Nye forbindelser
NO20031141D0 (no)	2003-03-12	Nye forbindelser
NO20034695D0 (no)	2003-10-20	Nye sammensetninger
NO20040066L (no)	2004-03-01	Nye antikonvulsivaderivater
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
NO20026162L (no)	2003-02-21	Nye forbindelser
NO20041185L (no)	2004-03-19	Nye sykloheksylsulfoner
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
IS2523B (is)	2009-07-15	Turn vindorkuvers

Legal Events

Date	Code	Title	Description
2015-04-27	MM1K	Lapsed by not paying the annual fees